Lenalidomide (Lenalid)
Each capsule contains lenalidomide 5 mg.
Lenalidomide is indicated for the treatment of multiple myeloma in combination with dexamethasone. It is also indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate- risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
- Presentation: Capsule
- Strength: 5 mg
- Pack Size: 30 capsules
- Manufacturing License: 50/UA/2006
View this product at gnhindia.com